HERNIATED DISC or LUMBAR FUSION SURGERY

This study will evaluate safety and effectiveness of a novel Hemostasis (to stop bleeding) compound placed in the surgery site during disc or fusion surgery. Disc herniation surgery involves removal of the herniated disc material from the vertebral column. The investigational drug is intended to reduce or stop bleeding, which is normal, without the use of standard methods; thus, reducing post operative pain and potential for scarring in the site. This is a placebo controlled study. 50% of subjects receive the investigational drug; 50% of the subjects receive the standard of care surgical approach to stop bleeding.